The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population

NCT00766558 | Completed DMC

• 1 other identifier: 28860
• Study Type: observational
• Target: 29
• Locations: 1 country
• Sites: 1

Brief Summary

A technique that has been found to be effective at relieving the physical and psychological symptoms associated with inhibiting emotions and emotional thoughts is written emotional disclosure. The goal of this study is to evaluate the effectiveness of written emotional disclosure on the remediation of eating disorder behaviour, cognitions, and management of emotions.

Conditions

Anorexia Nervosa; Bulimia Nervosa; Eating Disorder

Keywords

anorexia; bulimia; eating disorder not otherwise specified

Outcome Measures

Primary Outcomes (1)

• Testing and behavioral changes

  6-weeks

Study Arms (2)

1 Disclosure

Traumatic writing prompts provided. Participant is assigned a potential stress-producing topic for written disclosure.

2 control

Received nontraumatic writing prompts. Participant assigned a non-stressful writing condition

Eligibility Criteria

• Age: 14 Years - 50 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Patients in the Penn State Hershey Adolescentand Adult Eating Disorders Partial Hospitalization Program

You may qualify if:

• Willing to sign consent form

You may not qualify if:

• Unwilling to sign consent form

Sponsors & Collaborators

• Milton S. Hershey Medical Center: lead

Study Sites (1)

Penn State College of Medicine

Hershey, Pennsylvania, 17033, United States

Location

Related Publications (6)

• Pennebaker, J. W., Chung, C. K., Ireland, M., Gonzales, A., and Booth, R. J. (2007). The development and psychometric properties of LIWC2007. Retrieved June 1, 2008, from Linguistic Inquiry and Word Count web site http://www.LIWC.net/liwcdescription.php

  BACKGROUND

• Pennebaker, J. W. and Francis, M. E. (1996). Cognitive, emotional, and language processes in disclosure. Cognition and Emotion, 10, 601-626.

  BACKGROUND

• Pennebaker JW, Kiecolt-Glaser JK, Glaser R. Disclosure of traumas and immune function: health implications for psychotherapy. J Consult Clin Psychol. 1988 Apr;56(2):239-45. doi: 10.1037//0022-006x.56.2.239. No abstract available.

  PMID: 3372832 BACKGROUND

• Petrie KJ, Booth RJ, Pennebaker JW. The immunological effects of thought suppression. J Pers Soc Psychol. 1998 Nov;75(5):1264-72. doi: 10.1037//0022-3514.75.5.1264.

  PMID: 9866186 BACKGROUND

• Petrie KJ, Fontanilla I, Thomas MG, Booth RJ, Pennebaker JW. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom Med. 2004 Mar-Apr;66(2):272-5. doi: 10.1097/01.psy.0000116782.49850.d3.

  PMID: 15039514 BACKGROUND

• Quinton, S. and Wagner, H. L. (2005). Emotional expression, alexithymia, and characteristics associated with eating psychopathology in non-clinical women. Personality and Individual Differences, 38, 1163-1173.

  BACKGROUND

MeSH Terms

Conditions

Anorexia Nervosa; Bulimia Nervosa; Feeding and Eating Disorders; Anorexia; Bulimia

Condition Hierarchy (Ancestors)

Mental Disorders; Signs and Symptoms, Digestive; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Hyperphagia

Study Officials

• Richard L Levine, MD

  Penn State College of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 3, 2008
• First Posted: October 6, 2008
• Study Start: June 1, 2009
• Primary Completion: June 1, 2010
• Study Completion: July 1, 2013
• Last Updated: June 20, 2017

Record last verified: 2017-06

Locations

US (1)